vocabria

Generic: cabotegravir sodium

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vocabria
Generic Name cabotegravir sodium
Labeler viiv healthcare company
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

cabotegravir sodium 30 mg/1

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-248
Product ID 49702-248_6039b41a-e8a1-4976-bcbc-0fd7b70e423c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA212887
Listing Expiration 2026-12-31
Marketing Start 2021-01-21

Pharmacologic Class

Classes
hiv integrase inhibitors [moa] human immunodeficiency virus integrase strand transfer inhibitor [epc] organic anion transporter 1 inhibitors [moa] organic anion transporter 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702248
Hyphenated Format 49702-248

Supplemental Identifiers

RxCUI
2475199 2475205
UNII
3L12PT535M

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vocabria (source: ndc)
Generic Name cabotegravir sodium (source: ndc)
Application Number NDA212887 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)
source: ndc

Packages (1)

49702-248-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)

Ingredients (1)

cabotegravir sodium (30 mg/1)

Linked Drug Pages (1)

Vocabria ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6039b41a-e8a1-4976-bcbc-0fd7b70e423c", "openfda": {"unii": ["3L12PT535M"], "rxcui": ["2475199", "2475205"], "spl_set_id": ["66d450fb-cca4-476c-b0c7-c0730e3e4cf3"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)", "package_ndc": "49702-248-13", "marketing_start_date": "20210121"}], "brand_name": "Vocabria", "product_id": "49702-248_6039b41a-e8a1-4976-bcbc-0fd7b70e423c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Organic Anion Transporter 1 Inhibitors [MoA]", "Organic Anion Transporter 3 Inhibitors [MoA]"], "product_ndc": "49702-248", "generic_name": "cabotegravir sodium", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vocabria", "active_ingredients": [{"name": "CABOTEGRAVIR SODIUM", "strength": "30 mg/1"}], "application_number": "NDA212887", "marketing_category": "NDA", "marketing_start_date": "20210121", "listing_expiration_date": "20261231"}